Collaboration

Woman talking to a doctor
#BioInnovation Institute #Collaboration #Ferring Pharmaceuticals #Partnership #Start-ups #Women's health

Partners accelerate innovation in underserved women’s health

BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals have expanded their collaboration with the objective to accelerate world-class life science innovation within women’s health. New activities will include supporting BII to source and potentially fund and incubate early-stage start-ups and projects within the field of reproductive medicine. Read More

#News

Human breast cancer cells stained for DNA
#Cancer research #Collaboration #DNA #NeoPhore #Oncology #Partnership #The Institute of Cancer Research

Immuno-oncology collaboration to develop new type of cancer drug

Scientists at The Institute of Cancer Research, London, are teaming up with small molecule neoantigen immuno-oncology company NeoPhore to develop new potential cancer drugs. Under a new strategic research collaboration, an ICR team led by Professor Chris Lord will investigate the effect of NeoPhore’s inhibitors on… Read More

#Business & Investment #News

#allogeneic cell therapies #Cell therapy #Collaboration #Diabetes #Imagine Pharma #LyGenesis #Partnership #Type 1 diabetes

Collaboration will advance cell therapies for type 1 diabetes

LyGenesis and Imagine Pharma have entered into a joint research collaboration to develop novel cell therapies for patients with type 1 diabetes. The research collaboration will use Imagine Pharma’s Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs) and LyGenesis’ allogeneic cell therapy platform to develop… Read More

#Business & Investment #News

Telecommunications network North America
#Cancer research #Collaboration #Drug discovery #IRBM #Italy #Oncology #United States

Only non-US company joins cancer drug discovery consortium

Italian research institute and contract research organisation IRBM has become the only company from outside the United States to join cancer drug discovery network the Chemical Biology Consortium (CBC). The CBC is the discovery engine of the National Cancer Institute (NCI) Experimental Therapeutics (NExT) Program, administered… Read More

#Cancer Research #News

Peptide
#Cancer research #Collaboration #Evergreen Discovery #Hit identification #Orbit Discovery #Partnership #Peptides

Companies partner to identify cell targeting peptides

Companies Evergreen Discovery and Orbit Discovery have entered into a collaboration to identify specific cell targeting peptides and advance the development of novel radiopharmaceuticals. The agreement covers activities including designing peptide libraries, hit identification and hit validation to confirm cell surface binding properties. The… Read More

#Business & Investment #News

#Biopharmaceuticals #Collaboration #Contract Research Organisations (CROs) #Cryo-EM #Drug research #Immunology #Oncology

What’s next for this integrated drug discovery collaboration? 

Galapagos and NovAliX have entered a strategic collaboration in which Galapagos’ research and discovery capabilities and exclusively related employees based in Romainville, France, will be transferred to NovAliX, a drug discovery-focused Contract Research Organisation. The agreement follows Galapagos’ renewed focus on its key therapeutic areas of oncology and… Read More

#News

Modern medical science laboratory
#Astellas Pharma #Cancer research #Collaboration #Computer modelling #Immuno-oncology #MIMETAS #Oncology #Partnership

Improving immuno-oncology therapies using tumour modelling

Astellas Pharma and MIMETAS, which specialises in human disease modelling, have entered a strategic partnership to develop treatments for cancer. The companies will use MIMETAS’ tumour models to support the next generation of immuno-oncological therapies. “We are excited to make this next step in… Read More

#Cancer Research #News

Treg cells
#Autoimmune disease #Collaboration #Partnership #Regeneron Pharmaceuticals #Sonoma Biotherapeutics #T cell activation

Companies combine efforts on Treg therapies for autoimmune diseases

Sonoma Biotherapeutics and Regeneron Pharmaceuticals have announced plans to collaborate on the discovery, development and commercialisation of novel regulatory T cell (Treg) therapies for autoimmune diseases. The collaboration will bring together Regeneron’s VelociSuite technologies for the discovery and characterisation of fully human antibodies and T cell… Read More

#News

PD-L1 antibody
#Antibody #Cancer research #Collaboration #Merck #Oncology #Pfizer

Merck buys full rights to cancer drug Bavencio from Pfizer

Merck has bought the exclusive worldwide rights to develop, manufacture and commercialise anti PD-L1 antibody Bavencio (avelumab) from Pfizer. Merck will take full control of the global commercialisation of Bavencio through its affiliate Ares Trading. The transaction has also ended a long-term collaboration between Merck and… Read More

#Business & Investment #News

Macrophages
#Antibodies #Cancer research #Collaboration #Immuno-oncology #Japan #Macrophages #Oncology #Partnership #UK

Drug discovery partners from UK and Japan target macrophages

Macomics and Ono Pharmaceutical have entered a worldwide drug discovery collaboration agreement to develop new immuno-oncology antibody drugs against a novel macrophage target of interest in cancer. Under the terms of the agreement, Macomics will identify and characterise antibody candidates against the novel target of interest… Read More

#Cancer Research #News

#Collaboration #Drug development #Drug discovery #Partnership

Industry collaborations advancing drug discovery

Strategic research partnerships bring together knowledge, expertise and technologies, allowing advancements in our understanding of diseases and therapeutics that would not be possible in isolation. Optibrium and PostEra integrate AI drug discovery solutions Optibrium and PostEra plan to integrate Optibrium’s StarDrop platform with PostEra’s Manifold software. Read More

#Editor's Choice #News

Antibodies attack cancer cell
#Antibodies #Cancer research #Cancer Research UK #Collaboration #Oncology #Partnership #UCB

CRUK and UCB advance oncology antibody candidates

Cancer Research UK and UCB have agreed a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates through clinical trials. The collaboration focuses on the development of two investigational antibody candidates, UCB6114 and UCB4594, by bringing together the oncology-focused translational research and clinical… Read More

#Cancer Research #News

African medical researchers
#Africa #AI / data analytics / healthtech / informatics #Collaboration #Collaborative Drug Discovery (CDD) #Data management #Drug discovery

Informatics resource advances drug discovery in Africa

African researchers are now able to access Collaborative Drug Discovery’s CDD Vault resource for neglected disease drug discovery collaborations.  Collaborative Drug Discovery (CDD), a scientific informatics company that provides data management and analysis solutions, is offering free subscriptions to CDD Vault for select academic teams of scientists… Read More

#News

#Collaboration #Pharma Innovation Council #Pharmaceutical industry #Pistoia Alliance

Pharma Innovation Council will tackle industry barriers

The Pistoia Alliance Pharma Innovation Council has been launched, bringing together 13 leaders from large global pharmaceutical companies.   The Council will explore common challenges at a grassroots level and seed ideas for new pre-competitive projects aligned with the Alliance’s strategic themes: Emerging Sciences and Technology, Improving the… Read More

#News

Clinical trial
#Clinical trial design #Clinical trials #Collaboration #Duke Clinical Research Institute #Partnership #Protas

Research organisations partner to transform clinical trials

The Duke Clinical Research Institute (DCRI) and Protas, led by Oxford University clinical trialist Professor Sir Martin Landray, will collaborate to develop new approaches to large randomised clinical trials.  Through the collaboration, the partners hope to enable better evidence-based treatments for common conditions, such as heart and… Read More

#News